Cargando…

Quadrivalent HPV vaccine effectiveness against high‐grade cervical lesions by age at vaccination: A population‐based study

Human papillomavirus (HPV) types 16/18, included in HPV vaccines, contribute to the majority of cervical cancer, and a substantial proportion of cervical intraepithelial neoplasia (CIN) grades 2/3 or worse (CIN2+/CIN3+) including adenocarcinoma in situ or worse. The aim of this study was to quantify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herweijer, Eva, Sundström, Karin, Ploner, Alexander, Uhnoo, Ingrid, Sparén, Pär, Arnheim‐Dahlström, Lisen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Cancer Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069657/ https://www.ncbi.nlm.nih.gov/pubmed/26856527 http://dx.doi.org/10.1002/ijc.30035

Ejemplares similares

Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study
por: F, Lamb, et al.
Publicado: (2017)

The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study
por: Herweijer, Eva, et al.
Publicado: (2015)

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
por: Leval, Amy, et al.
Publicado: (2013)

Assessing Perceived Risk and STI Prevention Behavior: A National Population-Based Study with Special Reference to HPV
por: Leval, Amy, et al.
Publicado: (2011)

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study
por: Arnheim-Dahlström, Lisen, et al.
Publicado: (2013)

Opportunistic HPV vaccination at age 16–23 and cervical screening attendance in Sweden: a national register-based cohort study
por: Kreusch, Teresa, et al.
Publicado: (2018)

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program
por: Wang, Jiangrong, et al.
Publicado: (2019)

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study
por: Wang, Jiangrong, et al.
Publicado: (2016)

Sexually transmitted infections after bereavement – a population-based cohort study
por: Bond, Emily, et al.
Publicado: (2016)

Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study
por: Arnheim-Dahlström, Lisen, et al.
Publicado: (2012)

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination
por: Lamb, Favelle, et al.
Publicado: (2016)

Incidence of herpes zoster and associated events including stroke—a population-based cohort study
por: Sundström, Karin, et al.
Publicado: (2015)

Highest Vaccine Uptake after School-Based Delivery - A County-Level Evaluation of the Implementation Strategies for HPV Catch-Up Vaccination in Sweden
por: Rehn, Moa, et al.
Publicado: (2016)

Impact of HPV vaccination on cervical screening performance: a population-based cohort study
por: Lei, Jiayao, et al.
Publicado: (2020)

Impact of HPV vaccination on outcome of cervical cytology screening in Denmark—A register‐based cohort study
por: Thamsborg, Lise Holst, et al.
Publicado: (2018)

What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
por: Landy, Rebecca, et al.
Publicado: (2017)

Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland
por: Pollock, K G J, et al.
Publicado: (2014)

Parental acceptance and knowledge of varicella vaccination in relation to socioeconomics in Sweden: A cross-sectional study
por: Arnheim-Dahlström, Lisen, et al.
Publicado: (2021)

Incidence of cervical precancerous lesions and cervical cancer in Denmark from 2000 to 2019: Population impact of multi‐cohort vaccination against human papillomavirus infection
por: Ring, Linea Landgrebe, et al.
Publicado: (2022)

Short-term and long-term case-fatality rates for myocardial infarction and ischaemic stroke by socioeconomic position and sex: a population-based cohort study in Sweden, 1990–1994 and 2005–2009
por: Malki, Ninoa, et al.
Publicado: (2019)

Overall and Cervical Cancer Survival in Patients With and Without Mental Disorders
por: Herweijer, Eva, et al.
Publicado: (2023)

Sexual and testing behaviour associated with Chlamydia trachomatis infection: a cohort study in an STI clinic in Sweden
por: Veličko, Inga, et al.
Publicado: (2016)

Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions
por: Paz-Zulueta, María, et al.
Publicado: (2018)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions
por: Ma, Mingjun, et al.
Publicado: (2022)

Ongoing inadequacy of quadrivalent HPV vaccine safety studies
por: Little, Deirdre T, et al.
Publicado: (2020)

Human papillomavirus genotypes in cervical and other HPV‐related anogenital cancer in Rwanda, according to HIV status
por: Mpunga, Tharcisse, et al.
Publicado: (2019)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion
por: Ravilla, Rahul, et al.
Publicado: (2019)

Worldwide burden of cancer attributable to HPV by site, country and HPV type
por: de Martel, Catherine, et al.
Publicado: (2017)

Role of human papillomavirus status after conization for high‐grade cervical intraepithelial neoplasia
por: Huang, Huei‐Jean, et al.
Publicado: (2020)

Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection
por: Li, Chenxi, et al.
Publicado: (2023)

Transmission reduction and prevention with HPV vaccination (TRAP-HPV) study protocol: a randomised controlled trial of the efficacy of HPV vaccination in preventing transmission of HPV infection in heterosexual couples
por: MacCosham, Aaron, et al.
Publicado: (2020)

High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine
por: Hooi, Desiree J, et al.
Publicado: (2018)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania
por: Cunningham, Melissa S, et al.
Publicado: (2015)

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
por: Wang, Jiangrong, et al.
Publicado: (2017)

Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study
por: McBride, Emily, et al.
Publicado: (2019)

High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012–2019
por: Wang, Jiangrong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_310283e1sqioarbgqel4de8s44